Pfizer JKI 5 (Xeljanz 5 mg)

Generic Name: tofacitinib

Pill imprint Pfizer JKI 5 has been identified as Xeljanz 5 mg.

Xeljanz is used in the treatment of rheumatoid arthritis and belongs to the drug class antirheumatics. Risk cannot be ruled out during pregnancy. Xeljanz 5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Xeljanz

Generic Name:

tofacitinib

Imprint:

Pfizer JKI 5

Strength:

5 mg

Color:

White

Shape:

Round

Availability:

Prescription only

Drug Class:

Antirheumatics

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Pfizer, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.